Sanofi-Aventis Administrative Office
About Sanofi-Aventis Administrative Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
73
AstraZeneca
1
Clinical Trials at Sanofi-Aventis Administrative Office
During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-04-01
2014-12-01
Completed
3,222
Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
2001-06-01
2003-07-01
Completed
35
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
2002-03-01
2003-10-01
Completed
1,000
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
2002-02-01
2003-10-01
Completed
1,000
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
2002-10-01
2005-08-01
Completed
15,603
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
2003-08-01
2011-12-01
Completed
12,537
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
2002-10-01
2006-12-01
Completed
20,506
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office"
#1 collaborator was "Bristol-Myers Squibb" with 10 trials as a collaborator, "Regeneron Pharmaceuticals" with 5 trials as a collaborator, "Cancer International Research Group (CIRG)" with 3 trials as a collaborator, "Groupe Oncologie Radiotherapie Tete et Cou" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Sanofi-Aventis Administrative Office
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are
"Atrial Fibrillation" (8 trials), "Ascites" (5 trials), "Atrial Flutter" (4 trials), "Diabetes Mellitus, Type 2" (4 trials) and "Liver Cirrhosis" (4 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office
Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (73 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (11 trials), "Placebo" (10 trials), "Rimonabant" (5 trials), "5-Fluorouracil" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis Administrative Office
The vast majority of trials in "Sanofi-Aventis Administrative Office" are
64 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Sanofi-Aventis Administrative Office
Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 55 completed trials in Sanofi-Aventis Administrative Office,
undefined suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 56 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 0 trials that are defined as “Not Applicable".